Porcine Reproductive and Respiratory Syndrome Vaccine, Live

• Varieties: Vaccine
• Component: Virus
• Type: The First Class
• Shipping Cost: Estimated freight per unit.: about shipping cost and estimated delivery time.
• Currency: US$
• Return&refunds: You can apply for a refund up to 30 days after receipt of the products.
• Model NO.: CH-1R Strain
• Pharmacodynamic Influential Factors: Virus
• Storage Method: Prevent High or LowTemperature
• Veterinary Reg. No.: 154391063
• Usage: Administer Via Intramuscular Injection in The Neck
• Shelf Life: 18 Months
• Temperature: Store at -20ºC
• Withdrawal Period: 0 Day
• Package: 700 Bottles / Carton
• Transport Package: Air Way/Sea Way
• Specification: 5 dose/vial; 25 doses/ vial.
• Trademark: SINDER
• Origin: China
• Production Capacity: 100000L/Year
• Package Size: 61.20cm * 34.50cm * 41.00cm
• Package Gross Weight: 20.000kg

Product Description

GENERIC NAME:
Porcine Reproductive and Respiratory Syndrome Vaccine, Live (CH-1R Strain)
COMPOSITION:
Porcine Reproductive and Respiratory Syndrome Virus ≥ 10^5.0TCID₅₀/dose.
CHARACTERISTIC:
Yellow-white sponge-like loose clusters, rapidly dissolves in PBS to form a uniform suspension.
INDICATION(S):
The product is used for the prevention of porcine reproductive and respiratory syndrome. The duration of immunity is 4 months.
ADMINISTRATION AND DOSAGE:
Administered via intramuscular injection in the neck. Immunization for piglets at 3-4 weeks of age is 1 dose/head, and for sows, immunization is recommended one week before mating at 2 doses/head.
SPECIAL WARNING IF NECESSARY:

1. Pig farms applying this vaccine for the first time should conduct a preliminary trial on a small group.
2. Exercise caution when using on breeding boars.
3. Strictly disinfect the injection site.
4. Vaccine vials and related equipment must be thoroughly disinfected after use.
5. Vaccination is prohibited within 30 days before slaughter.
6. Use under the guidance of a veterinarian.
7. The vaccine's efficacy against variant strains has not been tested; therefore, its effectiveness against variant strains remains undetermined

 Porcine reproductive and respiratory syndrome vaccine, live (CH-1R strain)
(1) Classic lentogenic virus strain with extremely high safety: The farrowing is still good after the pregnant sows were vaccinated with a high dosage.
(2) Stable genetic traits: The CH-1R strain is classic lentogenic virus and gentical stable, the seed strain is passaged for more than 100 generations. The homology between the virus before and after passage is 99.2%.
(3) Stable antigen titer: small batch difference and brown vaccine bottles prevent UV damage to vaccine potency.
(4) Challenge test showed the product has cross protective effect on mutant strains.
(5) Triple detections of raw materials, production processes, and finished products to ensure no contamination by mycoplasma or other exogenous pathogens.

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.